Remission rates increase substantially by adding adalimumab to methotrexate and intra-articular glucocorticoid in patients with early rheumatoid arthritis – 1-year results of investigator-initiated, double-blinded randomized clinical trial (OPERA).

Kim Hørslev-Petersen; Merete Lund Hetland; P. Junker; Jan Pødenphanth; T. Ellingsen; P. Ahlquist; Hanne Merete Lindegaard; A. Linauskas; Annette Schlemmer; M.Y. Dam; I. Hansen; H.C. Horn; A. Jørgensen; Sophine Boysen Krintel; J. Raun; C.G. Ammitzbøll; Julia Sidenius Johansen; Mikkel Østergaard; K. Stengaard-Pedersen

Remission rates increase substantially by adding adalimumab to methotrexate and intra-articular glucocorticoid in patients with early rheumatoid arthritis – 1-year results of investigator-initiated, double-blinded randomized clinical trial (OPERA).

Kim Hørslev-Petersen, Merete Lund Hetland, P. Junker, Jan Pødenphanth, T. Ellingsen, P. Ahlquist, Hanne Merete Lindegaard, A. Linauskas, Annette Schlemmer, M.Y. Dam, I. Hansen, H.C. Horn, A. Jørgensen, Sophine Boysen Krintel, J. Raun, C.G. Ammitzbøll, Julia Sidenius Johansen, Mikkel Østergaard, K. Stengaard-Pedersen

Originalsprog	Engelsk
Bogserie	Scandinavian Journal of Rheumatology. Supplement
Vol/bind	41
Udgave nummer	126 suppl.
Sider (fra-til)	17-8
Antal sider	2
ISSN	1502-7740
Status	Udgivet - 2012

Andre filer og links

http://www.abstracts2view.com/eular/view.php?nu=EULAR12L_FRI0148

Citationsformater

Hørslev-Petersen, K., Hetland, M. L., Junker, P., Pødenphanth, J., Ellingsen, T., Ahlquist, P., Lindegaard, H. M., Linauskas, A., Schlemmer, A., Dam, M. Y., Hansen, I., Horn, H. C., Jørgensen, A., Krintel, S. B., Raun, J., Ammitzbøll, C. G., Johansen, J. S., Østergaard, M., & Stengaard-Pedersen, K. (2012). Remission rates increase substantially by adding adalimumab to methotrexate and intra-articular glucocorticoid in patients with early rheumatoid arthritis – 1-year results of investigator-initiated, double-blinded randomized clinical trial (OPERA). Scandinavian Journal of Rheumatology. Supplement, 41(126 suppl.), 17-8.

Remission rates increase substantially by adding adalimumab to methotrexate and intra-articular glucocorticoid in patients with early rheumatoid arthritis – 1-year results of investigator-initiated, double-blinded randomized clinical trial (OPERA). / Hørslev-Petersen, Kim; Hetland, Merete Lund; Junker, P. et al.

I: Scandinavian Journal of Rheumatology. Supplement, Bind 41, Nr. 126 suppl., 2012, s. 17-8.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Hørslev-Petersen, K, Hetland, ML, Junker, P, Pødenphanth, J, Ellingsen, T, Ahlquist, P, Lindegaard, HM, Linauskas, A, Schlemmer, A, Dam, MY, Hansen, I, Horn, HC, Jørgensen, A, Krintel, SB, Raun, J, Ammitzbøll, CG, Johansen, JS , Østergaard, M & Stengaard-Pedersen, K 2012, 'Remission rates increase substantially by adding adalimumab to methotrexate and intra-articular glucocorticoid in patients with early rheumatoid arthritis – 1-year results of investigator-initiated, double-blinded randomized clinical trial (OPERA).', Scandinavian Journal of Rheumatology. Supplement, bind 41, nr. 126 suppl., s. 17-8.

Hørslev-Petersen K, Hetland ML, Junker P, Pødenphanth J, Ellingsen T, Ahlquist P et al. Remission rates increase substantially by adding adalimumab to methotrexate and intra-articular glucocorticoid in patients with early rheumatoid arthritis – 1-year results of investigator-initiated, double-blinded randomized clinical trial (OPERA). Scandinavian Journal of Rheumatology. Supplement. 2012;41(126 suppl.):17-8.

Hørslev-Petersen, Kim ; Hetland, Merete Lund ; Junker, P. et al. / Remission rates increase substantially by adding adalimumab to methotrexate and intra-articular glucocorticoid in patients with early rheumatoid arthritis – 1-year results of investigator-initiated, double-blinded randomized clinical trial (OPERA). I: Scandinavian Journal of Rheumatology. Supplement. 2012 ; Bind 41, Nr. 126 suppl. s. 17-8.

@article{c839a785cdb34c40ad97bd68cae9f27e,

title = "Remission rates increase substantially by adding adalimumab to methotrexate and intra-articular glucocorticoid in patients with early rheumatoid arthritis – 1-year results of investigator-initiated, double-blinded randomized clinical trial (OPERA).",

author = "Kim H{\o}rslev-Petersen and Hetland, {Merete Lund} and P. Junker and Jan P{\o}denphanth and T. Ellingsen and P. Ahlquist and Lindegaard, {Hanne Merete} and A. Linauskas and Annette Schlemmer and M.Y. Dam and I. Hansen and H.C. Horn and A. J{\o}rgensen and Krintel, {Sophine Boysen} and J. Raun and C.G. Ammitzb{\o}ll and Johansen, {Julia Sidenius} and Mikkel {\O}stergaard and K. Stengaard-Pedersen",

year = "2012",

language = "English",

volume = "41",

pages = "17--8",

journal = "Acta rheumatologica Scandinavica",

issn = "0301-3847",

publisher = "Taylor & Francis",

number = "126 suppl.",

}

TY - ABST

T1 - Remission rates increase substantially by adding adalimumab to methotrexate and intra-articular glucocorticoid in patients with early rheumatoid arthritis – 1-year results of investigator-initiated, double-blinded randomized clinical trial (OPERA).

AU - Hørslev-Petersen, Kim

AU - Hetland, Merete Lund

AU - Junker, P.

AU - Pødenphanth, Jan

AU - Ellingsen, T.

AU - Ahlquist, P.

AU - Lindegaard, Hanne Merete

AU - Linauskas, A.

AU - Schlemmer, Annette

AU - Dam, M.Y.

AU - Hansen, I.

AU - Horn, H.C.

AU - Jørgensen, A.

AU - Krintel, Sophine Boysen

AU - Raun, J.

AU - Ammitzbøll, C.G.

AU - Johansen, Julia Sidenius

AU - Østergaard, Mikkel

AU - Stengaard-Pedersen, K.

PY - 2012

Y1 - 2012

UR - http://www.abstracts2view.com/eular/view.php?nu=EULAR12L_FRI0148

M3 - Conference abstract in journal

SN - 0301-3847

VL - 41

SP - 17

EP - 18

JO - Acta rheumatologica Scandinavica

JF - Acta rheumatologica Scandinavica

IS - 126 suppl.

ER -